No definition available.
Congenital malformations of great veins
DOID EFO Endpoint Browser PheWeb
Q17_CONGEN_MALFO_GREAT_VEINS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
107 |
4. Check minimum number of eventsNone |
107 |
5. Include endpointsNone |
107 |
6. Filter based on genotype QC (FinnGen only) |
107 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_CIRCULATO_SYSTEM
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q2
- Name in latin
- Malformationes congenitae venarum magnarum
Similar endpoints
↥List of similar endpoints to
Congenital malformations of great veins
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of the circulatory system
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1172 | 576 | 591 |
| Only index persons | 748 | 369 | 379 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 2.81 | 3.13 | 2.22 |
| Only index persons | 11.13 | 12.18 | 10.10 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 107 | 57 | 50 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 15.28 | 17.72 | 12.51 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 95
- Matched controls
- 936
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
195.1
50.5
49
5
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
380.0
46.1
43
*
Q26.1
ICD-10 Finland
Persistent left superior vena cava
+∞
44.1
39
*
Q26.3
ICD-10 Finland
Partial anomalous pulmonary venous connection
+∞
40.4
36
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
15.5
30.1
59
89
Q21.10
ICD-10 Finland
Persistent ostium secundum
+∞
29.6
27
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
18.3
25.1
41
37
GD1AA
NOMESCO Finland
Thorax X-ray examination
9.1
21.8
67
194
XF400
NOMESCO Finland
ECG with 12 standard connections
9.8
21.0
51
99
TPH07
NOMESCO Finland
Cathetrisation of artery
13.1
21.0
40
49
FM2CE
NOMESCO Finland
NA
18.3
19.6
31
24
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
13.7
19.2
35
38
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
26.6
18.9
26
13
ZXE20
NOMESCO Finland
More than three and less than five hours
11.5
18.8
38
51
C03DA01
ATC
spironolactone; oral
21.8
17.1
25
15
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
+∞
17.1
16
*
Q21.12
ICD-10 Finland
Defective sinus venosus
+∞
17.1
16
*
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
+∞
16.0
15
*
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
187.4
15.9
16
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.7
14.1
56
189
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
+∞
12.7
12
*
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
146.8
12.7
13
*
C03CA01
ATC
furosemide; systemic
8.3
12.4
29
47
XF404
NOMESCO Finland
Ambulatory ECG
10.9
12.4
24
28
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
11.6
12.3
23
25
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.5
12.1
35
77
Q25.0
ICD-10 Finland
Patent ductus arteriosus
+∞
11.6
11
*
Q26.8
ICD-10 Finland
Other congenital malformations of great veins
+∞
11.6
11
*
201
Kela drug reimbursment
Chronic cardiac insufficiency
28.9
11.5
15
6
XF402
NOMESCO Finland
ECG with work load test
11.2
11.1
21
23
XF600
NOMESCO Finland
Bloodpressure measurement
7.5
10.9
27
47
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
66.9
10.8
12
*
ZXD10
NOMESCO Finland
Scheduled procedure
4.4
10.8
59
252
ZXE40
NOMESCO Finland
More than seven and less than nine hours
21.6
10.6
15
8
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
+∞
10.6
10
*
B01AA03
ATC
warfarin; systemic
8.2
9.8
22
33
31
HP
Congenital heart failure surgery
+∞
9.5
9
*
Q20.1
ICD-10 Finland
Double outlet right ventricle
+∞
9.5
9
*
WX892
NOMESCO Finland
Monitored bed care
6.4
9.5
26
52
ZXE10
NOMESCO Finland
More than one and less than three hours
4.0
9.4
50
202
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
17.7
9.3
14
9
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
20.9
9.2
13
7
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
26.7
9.1
12
5
TPH04
NOMESCO Finland
Cathetrisation of vein
4.7
8.9
34
99
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.5
8.9
17
19
I50.9
ICD-10 Finland
Heart failure, unspecified
12.3
8.6
15
14
UGC02
NOMESCO Finland
Rigid bronchoscopy
97.1
8.5
9
*
XF622
NOMESCO Finland
Measurement of minute volume of heart
97.1
8.5
9
*
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
+∞
8.4
8
*
ZXD05
NOMESCO Finland
Urgent procedure
4.0
8.3
41
149
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.7
8.1
45
182
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
+∞
7.3
7
*
Q21.19
ICD-10 Finland
Atrial septal defect NOS
+∞
7.3
7
*
Q21.21
ICD-10 Finland
Atrioventricular duct
+∞
7.3
7
*
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
7.3
7
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
32.3
7.2
9
*
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
15.1
7.0
11
8
WX872
NOMESCO Finland
Intensive care
18.1
6.9
10
6
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
18.1
6.9
10
6
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
42.6
6.8
8
*
WX402
NOMESCO Finland
General anaesthesia
3.5
6.7
36
138
Z01.8
ICD-10 Finland
Other specified special examinations
4.0
6.6
28
88
Z3231
NOMESCO Finland
Registered nurse
3.1
6.4
51
257
ZX120
NOMESCO Finland
Intravenous
4.8
6.3
21
52
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
28.4
6.3
8
*
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
+∞
6.3
6
*
FFC96
NOMESCO Finland
Other closure of isolated atrial septal defect
+∞
6.3
6
*
XF620
NOMESCO Finland
Examination of circulation with color method
+∞
6.3
6
*
62
HP
Catheterization and pressure measurement of the right side of the heart
+∞
6.3
6
*
Q25.41
ICD-10 Finland
Persistent right-sided aortic arch
+∞
6.3
6
*
FFG96
NOMESCO Finland
Other correction of total anomalous pulmonary vein drainage
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
42
65
9.92
28.19
12.5
13.5
%
81.2
89.9
1.32
42
65
(3032080) INR in Blood by Coagulation assay
71
201
8.46
27.20
14.1
5.9
inr
1.0
1.2
—
6
58
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
60
173
6.57
21.52
4.5
3.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
25
12.01
21.22
23.1
25.2
u/ml
0.3
0.4
0.07
16
17
(3012095) Magnesium [Moles/volume] in Serum or Plasma
50
130
6.30
19.80
16.2
13.7
mmol/l
0.8
0.8
0.48
50
124
(3044640) Blood type and Crossmatch panel - Blood
63
222
5.42
17.13
4.8
3.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
75
313
5.62
16.37
5.4
4.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
42
114
5.38
15.35
13.7
17.1
mmol/l
5.4
5.4
0.04
42
109
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
15
14
12.22
13.96
3.8
6.6
%
87.4
102.9
0.76
15
14
(3000991) Gas panel - Venous blood
52
194
4.24
12.28
14.6
11.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
31
7.19
11.54
21.5
15.7
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
21
42
5.94
10.45
18.7
16.0
mmol/l
23.9
24.2
0.16
21
42
(3003396) Base excess in Arterial blood by calculation
27
68
4.94
10.43
16.9
11.9
mmol/l
-0.2
0.6
0.46
22
52
(3002032) Base excess in Venous blood by calculation
50
209
3.58
9.54
8.3
12.5
mmol/l
1.3
1.2
0.09
44
159
(3022313) Gas panel - Capillary blood
47
191
3.58
9.34
18.3
12.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
24
60
4.83
9.29
7.1
8.2
%
179.5
180.7
0.03
24
60
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
46
192
3.42
8.65
16.9
11.9
mmol/l
24.9
23.8
3.35
46
192
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
8
0
+∞
8.42
1.9
0.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
48
211
3.29
8.22
17.8
12.6
kpa
5.1
5.0
0.67
48
203
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
211
3.29
8.22
17.8
12.6
mmol/l
1.8
0.9
1.66
42
150
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
76
441
3.46
8.08
20.5
14.5
mmol/l
1.2
1.2
1.38
70
410
(3023368) Bacteria identified in Blood by Culture
42
175
3.28
7.80
4.3
4.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
39
156
3.33
7.73
7.0
5.2
mg/l
1.7
2.8
0.37
34
126
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
50
233
3.12
7.65
21.4
18.8
mmol/l
25.5
24.4
2.36
50
233
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
15
8.01
7.64
1.5
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
52
249
3.09
7.57
1.4
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
43
190
3.09
7.13
18.5
12.8
kpa
9.3
9.4
0.10
43
184
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
51
255
2.89
6.69
8.5
5.0
u/l
53.6
36.0
0.47
51
243
(3024928) Oxygen saturation in Venous blood
13
25
5.74
6.62
5.1
32.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
28
100
3.41
6.54
3.3
2.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
22
5.98
6.39
5.3
35.1
%
77.3
74.6
0.32
12
22
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
26
90
3.47
6.36
15.7
24.0
mg/l
1.1
1.1
0.54
26
90
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
17
45
4.27
6.03
4.3
22.6
%
1.1
1.3
0.46
17
45
(3019060) Gas panel - Arterial blood
11
21
5.69
5.60
6.3
5.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
37
169
2.80
5.59
5.4
3.6
ng/l
59.2
47.1
0.14
22
99
(3003458) Phosphate [Moles/volume] in Serum or Plasma
42
206
2.69
5.52
17.5
11.8
mmol/l
1.4
1.3
0.24
42
199
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
30
4.76
5.41
1.8
2.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
60
367
2.42
4.78
14.5
9.1
umol/l
23.5
26.8
0.24
55
351
(3000494) Fungus identified in Specimen by Culture
21
76
3.17
4.72
2.1
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
28
122
2.73
4.54
2.1
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
61
388
2.31
4.30
4.5
3.0
—
—
—
0
0
(44790049)
12
34
3.82
3.85
2.3
2.5
—
—
—
0
0
(44790048)
12
34
3.82
3.85
2.3
2.5
—
—
—
0
0
(44790047)
12
34
3.82
3.85
2.3
2.5
—
—
—
0
0
(44806118)
12
34
3.82
3.85
2.3
2.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
27
127
2.49
3.71
2.3
2.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
99
833
3.41
3.65
33.4
16.7
mmol/l
139.2
139.4
0.53
99
817
(3023103) Potassium [Moles/volume] in Serum or Plasma
99
830
3.47
3.65
33.3
16.6
mmol/l
4.1
4.0
2.26
99
810
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
46
3.33
3.64
2.1
2.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
100
846
3.66
3.61
22.4
13.3
umol/l
61.6
60.9
0.10
100
846
(40761511) CBC panel - Blood by Automated count
102
881
4.21
3.56
24.6
10.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
37
3.50
3.42
2.0
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
48
3.18
3.41
2.1
2.6
—
—
—
0
0
(4306422)
7
10
7.35
3.40
1.1
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
7
10
7.35
3.40
1.0
1.6
%
96.0
109.8
—
7
10
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
6
8
7.81
3.08
1.0
1.3
%
71.7
89.5
—
6
8
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
31
3.43
2.82
2.1
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
14
5.23
2.76
1.0
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
16
4.57
2.50
3.9
4.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
21
105
2.23
2.48
2.1
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
17
4.30
2.39
1.7
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
18
4.06
2.28
7.0
42.4
%
12.4
11.3
—
7
18
(3042733) HLA Ab [Presence] in Serum
5
9
5.72
2.22
2.2
2.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
105
2.10
2.09
2.0
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
6
15
4.14
2.05
9.3
4.2
kpa
9.1
8.6
—
6
15
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
11
4.68
1.95
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
16
3.88
1.95
2.3
3.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
31
197
1.79
1.87
2.6
2.6
—
—
—
0
0
(4268621)
5
12
4.28
1.83
2.0
2.1
—
—
—
0
0
(3002256) Pathology report gross observation
15
74
2.18
1.83
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
8
170
0.42
1.79
1.5
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
18
3.44
1.76
2.7
3.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
13
3.95
1.72
12.8
6.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
69
556
1.66
1.68
5.6
4.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
14
3.67
1.62
1.0
1.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
5
15
3.42
1.53
10.0
4.2
kpa
4.9
4.8
—
5
15
(3013512) EKG study
21
127
1.80
1.47
6.2
3.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
98
892
2.09
1.46
36.4
18.0
%
38.0
38.9
0.87
87
781
(3034770) Mitochondria Ab [Titer] in Serum
6
22
2.81
1.44
1.7
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
22
2.81
1.44
1.5
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
16
3.20
1.44
10.6
6.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
11
53
2.18
1.42
45.4
19.0
—
1.1
—
0
7
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
23
2.68
1.37
3.0
3.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
35
2.37
1.29
1.3
1.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
60
487
1.51
1.27
16.7
10.7
ml/min/173m2
88.2
92.8
0.56
42
364
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
12
63
2.01
1.26
4.0
6.6
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
11
56
2.06
1.25
2.8
2.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
95
859
1.88
1.24
32.9
18.6
%
13.8
13.4
1.94
95
852
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
37
2.24
1.23
4.4
8.6
%
53.9
60.1
—
8
37
(3004588) Protein electrophoresis panel - Serum or Plasma
5
19
2.69
1.22
1.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
26
2.37
1.19
1.0
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
36
0.00
1.16
0.0
1.6
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
5
20
2.55
1.15
1.6
1.7
ng/l
166.8
174.3
—
5
20
(3019225) pH of Specimen
7
31
2.33
1.12
3.9
7.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
21
2.43
1.09
9.2
11.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
52
2.00
1.08
5.2
3.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
43
337
1.45
1.03
4.1
4.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
50
1.86
0.99
1.7
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
6
27
2.28
0.95
2.7
2.0
u/ml
26.7
34.6
—
6
27
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
57
1.82
0.85
3.0
2.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
31
1.98
0.85
1.3
2.4
—
—
—
0
0
(3026782) Osmolality of Urine
25
183
1.47
0.84
2.9
3.5
mosm/kgh2o
562.0
587.5
0.23
20
155
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
0
25
0.00
0.80
0.0
2.1
—
0.2
—
0
19
(3045142) Bone marrow Pathology biopsy report
0
25
0.00
0.80
0.0
1.8
—
—
—
0
0
(3015736) pH of Urine
39
314
1.37
0.77
3.7
3.6
—
—
—
0
0
(3020891) Body temperature
5
23
2.21
0.77
4.8
9.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
54
1.72
0.76
1.3
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
26
329
0.72
0.73
2.3
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
7
43
1.66
0.68
1.3
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
43
1.66
0.68
2.7
1.9
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
44
1.62
0.66
1.6
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
44
1.62
0.66
1.6
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
30
239
1.34
0.62
3.6
3.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
30
1.69
0.61
3.6
3.5
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
30
1.69
0.61
1.0
1.0
g/l
155.2
166.2
—
5
30
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
19
0.00
0.61
0.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
19
0.00
0.61
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
22
0.00
0.60
0.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
204
1.35
0.59
1.7
2.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
52
452
1.28
0.57
11.3
11.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.65
0.56
1.2
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
9
62
1.48
0.54
4.4
3.3
—
—
—
0
0
(4010399)
9
63
1.46
0.53
1.9
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
64
1.43
0.53
1.4
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
172
1.34
0.52
1.4
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
45
1.58
0.50
2.1
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
35
296
1.26
0.47
4.2
4.1
e6/l
0.3
0.4
0.33
29
219
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
31
1.63
0.43
1.0
3.7
%
12.2
27.5
—
5
31
(40760892) CBC W Ordered Manual Differential panel - Blood
21
168
1.30
0.43
5.6
6.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
205
1.28
0.42
3.6
3.6
e6/l
1.1
0.7
0.43
15
126
(3044290) Cell count panel - Cerebral spinal fluid
5
32
1.58
0.42
1.0
7.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
32
1.58
0.42
1.2
1.3
—
—
—
0
0
(4198724)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
15
0.00
0.41
0.0
3.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
17
0.00
0.41
0.0
2.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
17
0.00
0.41
0.0
2.4
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
5
34
1.48
0.40
1.4
3.9
%
55.0
16.1
—
5
34
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
35
1.44
0.39
1.2
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
35
1.44
0.39
1.4
3.7
—
—
—
0
0
(3000492) Spirometry study
9
66
1.39
0.39
2.4
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
133
0.72
0.37
2.2
2.4
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
5
76
0.64
0.37
1.0
1.0
kpa
2.7
3.2
—
5
63
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
5
78
0.62
0.37
1.0
1.0
mmol/l
22.6
18.9
—
5
78
(3006598) pH of Arterial cord blood
5
78
0.62
0.37
1.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
5
78
0.62
0.37
1.0
1.0
mmol/l
0.5
-2.5
—
5
10
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
5
78
0.62
0.37
1.0
1.0
kpa
6.7
7.5
—
5
65
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
42
1.44
0.36
1.2
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
34
295
1.21
0.36
4.3
4.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
45
1.34
0.34
1.3
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
22
185
1.23
0.31
7.4
4.0
ph
7.4
7.4
—
6
31
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
149
0.77
0.29
2.1
2.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
33
366
0.85
0.28
1.3
1.8
u/ml
1.1
3.9
—
5
58
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
131
1.25
0.28
1.4
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
65
1.24
0.27
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
137
0.77
0.27
1.6
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
70
0.70
0.27
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
23
199
1.19
0.24
2.4
1.8
pmol/l
91.0
96.5
0.24
13
107
(3012516) Albumin [Mass/volume] in Urine
16
134
1.22
0.23
3.1
3.5
mg/l
13.4
146.4
—
10
101
(1761868) Lipid panel - Serum or Plasma
18
207
0.84
0.23
2.6
2.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
41
1.22
0.22
1.6
2.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
43
395
1.14
0.22
5.9
5.3
estimate
0.0
0.0
—
8
60
(3019198) Lymphocytes [#/volume] in Blood
56
589
0.88
0.21
11.1
9.9
e9/l
2.1
2.5
1.45
48
498
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
132.5
—
0
11
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
2.1
—
0
11
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(4094501)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
6.5
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
13.6
—
0
5
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
3.2
—
0
13
(3001604) Monocytes [#/volume] in Blood
55
578
0.89
0.20
11.3
9.8
e9/l
0.7
0.6
1.07
46
467
(44813793)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
53
557
0.89
0.19
14.2
12.0
e9/l
0.0
0.0
0.50
41
411
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
57
1.24
0.18
1.7
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
55
576
0.89
0.18
11.3
9.9
e9/l
0.0
0.0
0.35
46
466
(3022145) Colonoscopy Study observation
7
60
1.17
0.18
2.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
7
60
1.17
0.18
4.0
6.9
g/l
0.2
0.5
—
7
48
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
61
1.15
0.18
3.0
2.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
39
360
1.12
0.18
5.3
5.3
e6/l
26.2
47.1
0.38
30
251
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
21
233
0.87
0.17
1.3
2.2
—
—
—
0
0
(4035726)
8
70
1.15
0.16
5.4
1.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
43
402
1.10
0.15
4.2
3.6
estimate
0.0
0.0
—
8
58
(3029937) Albumin [Presence] in Urine by Test strip
18
200
0.87
0.15
5.2
3.8
estimate
0.0
0.0
—
8
60
(3007164) IgA [Mass/volume] in Serum or Plasma
34
362
0.90
0.15
1.4
1.8
g/l
2.1
1.6
0.99
22
176
(3035350) Ketones [Presence] in Urine by Test strip
43
403
1.10
0.14
4.1
3.6
estimate
0.0
0.0
—
7
61
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
95
0.82
0.14
2.9
2.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
201
1.11
0.11
4.0
3.7
e6/l
2.2
1.9
0.07
12
122
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
26
277
0.91
0.11
4.5
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
54
556
0.93
0.10
6.1
4.5
mmol/mol
38.3
38.4
0.04
47
520
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
13
115
1.14
0.10
8.2
4.8
%
20.7
21.9
—
7
59
(40761535) Cells panel - Urine sediment
5
45
1.11
0.10
4.8
3.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
45
1.11
0.10
1.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
39
370
1.07
0.09
9.8
8.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
69
0.86
0.08
2.0
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
9
83
1.08
0.07
1.8
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
98
1.13
0.07
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
8
89
0.88
0.07
2.9
1.7
%
1.4
1.4
—
8
79
(3013115) Eosinophils [#/volume] in Blood
58
591
0.95
0.06
12.1
10.8
e9/l
0.2
0.2
0.16
48
494
(3013650) Neutrophils [#/volume] in Blood by Automated count
64
625
1.04
0.04
11.2
13.6
e9/l
4.1
3.7
0.65
53
514
(3002582) Erythrocytes [#/volume] in Urine
33
318
1.04
0.03
4.5
4.3
e6/l
16.0
35.0
0.47
28
239
(40768797) Stomach Pathology biopsy report
11
102
1.08
0.02
2.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
18
186
0.95
0.01
3.4
3.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
62
609
1.03
0.01
4.6
3.8
mmol/l
4.1
4.5
2.38
56
562
(40768804) Tissue Pathology biopsy report
24
240
0.99
0.00
2.2
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
60
591
1.02
0.00
4.3
3.5
mmol/l
5.8
5.7
0.32
55
536
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
62
612
1.02
0.00
5.2
3.9
mmol/l
2.3
2.7
3.33
56
561
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
80
791
1.02
0.00
4.0
4.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
61
605
1.00
0.00
4.6
3.7
mmol/l
1.4
1.4
0.35
56
550
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
7
0.00
0.00
0.0
1.4
—
12.9
—
0
7
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
4.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
55.3
—
0
8
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
8
0.00
0.00
0.0
1.0
—
158.9
—
0
8
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
6
61
0.98
0.00
2.0
2.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
3.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.4
—
5.8
—
0
5
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
26.8
—
1715.4
—
0
5
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.0
—
20.0
—
0
5
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
6
60
0.99
0.00
1.0
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.1
—
28.5
—
0
9
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
3.7
—
0
6
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
8.0
—
35.6
—
0
5
(40768795) Lymph node Pathology biopsy report
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
2.8
—
169.1
—
0
6
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
6.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
25.1
—
0
8
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
22.8
—
9.9
—
0
6
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
1255.8
—
0
9
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.9
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
9
92
0.97
0.00
1.4
1.6
pmol/l
481.1
507.7
—
9
79
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
63
0.94
0.00
1.8
1.8
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
9
96
0.93
0.00
1.3
1.4
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
8
0.00
0.00
0.0
6.3
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
12.0
—
986.8
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
6.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.0
—
14.3
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_GREAT_VEINS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_GREAT_VEINS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_GREAT_VEINS – Congenital malformations of great veins
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data